RASAZILECT rasagiline mesilate1 mg tablets, bottle
देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
सार्वजनिक आकलन रिपोर्ट
(PAR)
16-05-2019
अनुरोध भेजा।
सक्रिय संघटक:
rasagiline mesilate, Quantity: 1.56 mg
थमां उपलब्ध:
Arrotex Pharmaceuticals Pty Ltd
फार्मास्यूटिकल फॉर्म:
Tablet, uncoated
रचना:
Excipient Ingredients: purified talc; microcrystalline cellulose; citric acid; silicon dioxide; pregelatinised maize starch; stearic acid; maize starch
प्रशासन का मार्ग:
Oral
पैकेज में यूनिट:
30
प्रिस्क्रिप्शन प्रकार:
(S4) Prescription Only Medicine
चिकित्सीय संकेत:
Rasagiline is indicated for the symptomatic treatment of idiopathic Parkinsons disease (PD) as monotherapy (without concomitant levodopa/decarboxylase inhibitor therapy) or as adjunct therapy (with concomitant levodopa/decarboxylase inhibitor therapy).
उत्पाद समीक्षा:
Visual Identification: White to off-white, round, flat bevelled tablets debossed with "C13" on one side and plain on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
प्राधिकरण का दर्जा:
Registered
प्राधिकरण की तारीख:
2018-01-23
